Galafold
Ended Awarded Last action
- Contract number
- 36C25925F0067
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $261,091
Award facts
- Contract value 100% obligated
- $261,090.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $8,017 | |
| Original award | $253,074 |
About this award
This is a federal contract award to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., for the delivery of Galafold (migalastat), an enzyme replacement therapy used to treat Fabry disease. The contract, valued at $261,090.68, is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has an ultimate completion date of November 14, 2025. Amicus Therapeutics US, LLC is the prime contractor, and no subcontractors are identified. The contract is not designated as a set-aside. The award demonstrates Amicus Therapeutics US, LLC's role as a critical supplier of specialized medications to the VA, supporting the agency's mission to provide healthcare services and treatments to veterans, including those with rare genetic diseases like Fabry disease.
Quick answers
Who was awarded contract 36C25925F0067?
36C25925F0067 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 19 (Veterans Health Administration) on November 15, 2024.
How much is contract 36C25925F0067 worth?
The government has obligated $261,091 on 36C25925F0067.
Is contract 36C25925F0067 an order under another contract?
Yes. 36C25925F0067 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25925F0067 competed?
The extent of competition for 36C25925F0067 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award